medical-device-investing Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases
pharmaceutical-investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
medical-device-investing Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results
pharmaceutical-investing Inovio and The Wistar Institute Receive More Than $4.6 Million in R&D Funding
Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data From Summit’s PhaseOut DMD Clinical Trial
Canada One Assays up to 9.96 g/t High-Grade Au with Cu and Ag at the Reco Target, Copper Dome Project
